DEVELOPING UPPER LIMB MOTOR BIOMARKERS OF DEMENTIA
With
Kaylee Rudd,
Junior Research Fellow,
Wicking Dementia Research and Education Centre
University of Tasmania, Hobart, Tasmania
RESEARCHER PROFILE
Filmed in Hobart, Tasmania, Australia | February 2026
Kaylee is currently a research fellow with the Wicking Dementia Research and Education Centre at the University of Tasmania. She has recently submitted her PhD thesis, reporting the findings of her research on developing upper limb motor biomarkers of dementia. She has postgrad degrees in physiotherapy and experience working in the community and aged care across Tasmania for several years, where she worked with people with dementia.
Her experience underlined the importance of detecting cognitive impairment early and prompted her to join the Wicking to research dementia in 2021. Her research aims to better understand how movement is associated with cognition and to identify potential hand motor tests to help detect those at risk of developing cognitive impairment early.
One of the main highlights of her research experience has been close and regular collaboration with participants and team members of the ISLAND Clinic and the Tasmanian ISLAND Project.
Currently she coordinates the TapTalk project, a multi-level RHHRF funded project, which aims to develop a non-invasive screening test to detect risk of Alzheimer’s disease pathology.
Kaylee also contributes to national and international research projects. Examples are her work with the multisite Australian Dementia Network (ADNeT) study investigating the impact of blood-based biomarkers knowledge on clinician’s diagnostic confidence, and her ongoing collaboration with the AI-assisted motor biomarkers team in the University of Leeds, UK.
Collaborations and funding from
- Wicking Dementia research and Education Centre, University of Tasmania
- Royal Hobart Hospital, Tasmanian Health Service
- Royal Hobart Hospital Research Foundation (RHHRF)
Source: Supplied and adapted
https://orcid.org/0000-0002-8073-8691
-
Liver cancer biomarkers, risk prediction & progression
Dr. Rodrigo Carlessi is an expert in Cancer Genomics and Molecular Biology, with an extensive track record in liver cancer research. He leads the Cancer Genomics Group within the Liver Disease and Regeneration Laboratory at the Curtin Medical Research Institute. He has an impressive publication record, with 43 manuscripts that have collectively garnered over 2,680 citations. His research leverages cutting-edge genomics and transcriptomics technologies, as well as long-read DNA sequencing, to explore mechanisms, identify biomarkers, and develop therapeutic targets in liver disease and cancer.
-
Risk factors and prevention of respiratory infections and infectious diseases in children
A/Prof Hannah Moore OAM is an infectious disease epidemiologist; Co-Head of the Infectious Disease Epidemiology team within the Wesfarmers Centre of Vaccines and Infectious Diseases at The Kids Research Institute Australia and Associate Professor at the School of Population Health, Curtin University in Western Australia.
A/Prof Moore has been awarded more than $19M in competitive research grants, co-authored more than 140 papers, was TEDxPerth 2018 speaker, recipient of a WA Young Tall Poppy Award (2013) and the WA Premiers Science Early Career Scientist Award (2015). In 2024, she was honoured with a Medal of the Order of Australia for her service to epidemiology as a researcher.
-
Interventions for improving outcomes of children who are deaf or hard of hearing
Professor Teresa Ching is a Conjoint Professor at NextSense Institute and Macquarie University, and an Honorary Professor at the University of Queensland in Australia. Her current research focuses on devising culturally sensitive practices in early detection and intervention to maximise children’s outcomes. Working with international colleagues, her current research is also directed towards developing global guidelines and recommendations for hearing screening beyond the newborn period, so that all children can benefit from early detection and intervention. The ultimate goal is to attain equity of care and outcomes for all children with hearing difficulties.
